These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1608895)

  • 1. Prediction and assessment of flammability hazards associated with metered-dose inhalers containing flammable propellants.
    Dalby RN
    Pharm Res; 1992 May; 9(5):636-42. PubMed ID: 1608895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Issues surrounding MDI formulation development with non-CFC propellants.
    Kontny MJ; Destefano G; Jager PD; McNamara DP; Turi JS; Van Campen L
    J Aerosol Med; 1991; 4(3):181-7. PubMed ID: 10147677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The challenge of reformulation.
    Smith IJ
    J Aerosol Med; 1995; 8 Suppl 1():S19-27. PubMed ID: 10150491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of metering chamber volume and water level on the emitted dose of a suspension-based pMDI containing propellant 134a.
    Williams RO; Liu J; Koleng JJ
    Pharm Res; 1997 Apr; 14(4):438-43. PubMed ID: 9144728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler.
    Williams RO; Repka M; Liu J
    Drug Dev Ind Pharm; 1998 Aug; 24(8):763-70. PubMed ID: 9876524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compatibility evaluation of metered-dose inhaler valve elastomers with tetrafluoroethane (P134a), a non-CFC propellant.
    Tiwari D; Goldman D; Dixit S; Malick WA; Madan PL
    Drug Dev Ind Pharm; 1998 Apr; 24(4):345-52. PubMed ID: 9876594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transition to CFC-free metered dose inhalers--into the new millennium.
    McDonald KJ; Martin GP
    Int J Pharm; 2000 May; 201(1):89-107. PubMed ID: 10867268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plume temperature emitted from metered dose inhalers.
    Brambilla G; Church T; Lewis D; Meakin B
    Int J Pharm; 2011 Feb; 405(1-2):9-15. PubMed ID: 21129465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balancing ethanol cosolvent concentration with product performance in 134a-based pressurized metered dose inhalers.
    Gupta A; Stein SW; Myrdal PB
    J Aerosol Med; 2003; 16(2):167-74. PubMed ID: 12823910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moisture transport into chlorofluorocarbon-free metered dose inhalers.
    Williams G
    J Allergy Clin Immunol; 1999 Dec; 104(6):S227-9. PubMed ID: 10588979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler.
    Donnell D; Harrison LI; Ward S; Klinger NM; Ekholm BP; Cooper KM; Porietis I; McEwen J
    Eur J Clin Pharmacol; 1995; 48(6):473-7. PubMed ID: 8582466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isobutane driven salbutamol sulfate metered dose inhaler: formulation selection and respiratory tract absorption in guinea pigs].
    Ding L; Zhang JS
    Yao Xue Xue Bao; 2009 Sep; 44(9):1040-5. PubMed ID: 20055182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical transition to non-CFC pressurized metered dose inhalers.
    Cripps A; Riebe M; Schulze M; Woodhouse R
    Respir Med; 2000 Jun; 94 Suppl B():S3-9. PubMed ID: 10919679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human safety and pharmacokinetics of the CFC alternative propellants HFC 134a (1,1,1,2-tetrafluoroethane) and HFC 227 (1,1,1,2,3,3, 3-heptafluoropropane) following whole-body exposure.
    Emmen HH; Hoogendijk EM; Klöpping-Ketelaars WA; Muijser H; Duistermaat E; Ravensberg JC; Alexander DJ; Borkhataria D; Rusch GM; Schmit B
    Regul Toxicol Pharmacol; 2000 Aug; 32(1):22-35. PubMed ID: 11029265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The change to non-CFC metered dose inhalers.
    Rubinfeld A
    Aust Fam Physician; 1997 Dec; 26(12):1412-4. PubMed ID: 9470296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metering performance of several metered-dose inhalers with different spacers/holding chambers.
    Berlinski A; Waldrep JC
    J Aerosol Med; 2001; 14(4):427-32. PubMed ID: 11791683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pressurized metered dose inhalers: chlorofluorocarbon to hydrofluoroalkane transition-valve performance.
    Cummings RH
    J Allergy Clin Immunol; 1999 Dec; 104(6):S230-6. PubMed ID: 10588980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the systemic pharmacodynamic effects and pharmacokinetics of salmeterol delivered by CFC propellant and non-CFC propellant metered dose inhalers in healthy subjects.
    Kempsford R; Handel M; Mehta R; De Silva M; Daley-Yates P
    Respir Med; 2005 Apr; 99 Suppl A():S11-9. PubMed ID: 15777604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of therapeutically equivalent alternatives to short acting beta(2) adrenoceptor agonists delivered via chlorofluorocarbon-containing inhalers.
    Hughes DA; Woodcock A; Walley T
    Thorax; 1999 Dec; 54(12):1087-92. PubMed ID: 10567628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A correlation equation for the mass median aerodynamic diameter of the aerosol emitted by solution metered dose inhalers.
    Ivey JW; Lewis D; Church T; Finlay WH; Vehring R
    Int J Pharm; 2014 Apr; 465(1-2):18-24. PubMed ID: 24524827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.